Efficacy of ACE Inhibitors, MRAs and ACE Inhibitor/ MRA Combination
Condition(s):Diabetic Nephropathy Type 2; Microalbuminuria Due to Type 2 Diabetes MellitusLast Updated:January 18, 2020Unknown status
Hide Studies Not Open or Pending
Condition(s):Diabetic Nephropathy Type 2; Microalbuminuria Due to Type 2 Diabetes MellitusLast Updated:January 18, 2020Unknown status
Condition(s):Transcatheter Aortic Valve Replacemen; Angiotensin-Converting Enzyme InhibitorsLast Updated:September 24, 2021Unknown status
Condition(s):Alport SyndromeLast Updated:November 24, 2021Not yet recruiting
Condition(s):Biopsy-confirmed IgA Nephropathy; Proteinuria Less Than 0.5 g Per Day; Normal Blood Pressure; Serum Creatinine Below 120 Umol/lLast Updated:October 21, 2010Completed
Condition(s):Coronary Artery Dissection, SpontaneousLast Updated:March 15, 2024Terminated
Condition(s):Atherosclerosis; Coronary Disease; VasculitisLast Updated:March 4, 2008Completed
Condition(s):Hypertension; Unspecified Adult Solid Tumor, Protocol SpecificLast Updated:August 28, 2018Terminated
Condition(s):End Stage Renal Failure on Dialysis; Complication of HemodialysisLast Updated:July 2, 2013Completed
Condition(s):Hypertension; Metabolic SyndromeLast Updated:November 18, 2013Withdrawn
Condition(s):Left Ventricular Function Systolic Dysfunction; Left Ventricular Function Diastolic Dysfunction; AgeingLast Updated:March 30, 2017Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.